Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The therapeutic efficacy of zinc gluconate lozenge therapy in experimentally induced rhinovirus infection was assessed in two randomized controlled trials in susceptible adult volunteers. In trial 1, lozenges containing either zinc gluconate (23 mg of elemental zinc) or placebo were given 36 h after nasal inoculation of rhinovirus type 39 and administered eight times per day for 5 days. All of the volunteers had early cold symptoms at the time that treatment was begun. In trial 2, the same lozenge regimen was used, beginning 2 h after nasal inoculation with rhinovirus type 13, and continued for 7 days. Zinc therapy did not reduce the severity or duration of cold symptoms or the frequency or duration of viral shedding in either trial. Viral titers were measured in trial 2 and were shown to be unaffected by zinc therapy. Nasal mucus weights and the numbers of paper tissues used were slightly higher in zinc recipients. A statistically significant increase in levels of zinc in serum was documented in zinc recipients after 5 days of therapy. These data suggest that zinc gluconate lozenge therapy is not therapeutically useful in the treatment of rhinovirus colds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study
Eby, G. A., Davis, D. R., & Halcomb, W. W. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.20 · Cited by 217 · cited 4×
“(4) was due to an effect against viruses other than rhinoviruses but if so, it would be”
BackgroundInfluentialEffects of ascorbic acid on the common cold
Chalmers, T. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90127-8 · Cited by 155 · cited 1×
“The problem of bias because of unblinding was noted by Chalmers to account for a trend toward efficacy in a randomized, controlled trial of ascorbic acid treatment of common colds (3).”
Background
Cited by
ZINC AND THE RISK FOR INFECTIOUS DISEASE
Walker, C. F., & Black, R. E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073054 · Cited by 491
Immune-enhancing role of vitamin C and zinc and effect on clinical conditions
Wintergerst, E. S., Maggini, S., & Hornig, D. H. (2006) · Annals of Nutrition and Metabolism · doi:10.1159/000090495 · Cited by 418
Singh, M., & Das, R. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001364.pub4 · Cited by 237
RetractedPrasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00006 · Cited by 228
“Two randomized, controlled trials examined viral shedding in volunteers who were inoculated with rhinovirus and were treated with zinc; the investigators concluded that zinc had no effect on this infection ( 9 ).”
BackgroundScience, M., Johnstone, J., Roth, D. E., Guyatt, G., & Loeb, M. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111990 · Cited by 157
Metadata
- Authors
- Farr, B. M., Conner, E. M., Betts, R. F., Oleske, J., Minnefor, A., & Gwaltney, J. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1987-08
- Volume
- 31
- Issue
- 8
- Pages
- 1183-1187
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2021401266
- Cited by
- 94
- References
- 2
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. https://app.cochat.ai/papers/10.1128/aac.31.8.1183
- The paper
- Farr, B. M., Conner, E. M., Betts, R. F., Oleske, J., Minnefor, A., & Gwaltney, J. M. (1987). Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.31.8.1183
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.